[1]
|
Haroon Al Rasheed, M.R. and Xu, B. (2019) Molecular Alterations in Thyroid Carcinoma. Surgical Pathology Clinics, 12, 921-930. https://doi.org/10.1016/j.path.2019.08.002
|
[2]
|
Cabanillas, M.E., Mcfadden, D.G. and Durante, C. (2016) Thyroid Cancer. The Lancet, 388, 2783-2795.
https://doi.org/10.1016/S0140-6736(16)30172-6
|
[3]
|
Saini, S., Tulla, K., Maker, A.V., et al. (2018) Therapeutic Advances in Anaplastic Thyroid Cancer: A Current Perspective. Molecular Cancer, 17, 154. https://doi.org/10.1186/s12943-018-0903-0
|
[4]
|
Xing, M., Haugen, B.R. and Schlumberger, M. (2013) Progress in Molecular-Based Management of Differentiated Thyroid Cancer. The Lancet, 381, 1058-1069. https://doi.org/10.1016/S0140-6736(13)60109-9
|
[5]
|
Beroun, A., Mitra, S., Michaluk, P., et al. (2019) MMPs in Learning and Memory and Neuropsychiatric Disorders. Cellular and Molecular Life Sciences, 76, 3207-3228. https://doi.org/10.1007/s00018-019-03180-8
|
[6]
|
Kapoor, C., Vaidya, S., Wadhwan, V., et al. (2016) Seesaw of Matrix Metalloproteinases (MMPs). Journal of Cancer Research and Therapeutics, 12, 28-35. https://doi.org/10.4103/0973-1482.157337
|
[7]
|
Chan, Z.C., Oentaryo, M.J. and Lee, C.W. (2020) MMP-Mediated Modulation of ECM Environment during Axonal Growth and NMJ Development. Neuroscience Letters, 724, Article ID: 134822.
https://doi.org/10.1016/j.neulet.2020.134822
|
[8]
|
Huang, H. (2018) Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors (Basel), 18, 3249. https://doi.org/10.3390/s18103249
|
[9]
|
Gobin, E., Bagwell, K., Wagner, J., et al. (2019) A Pan-Cancer Perspective of Matrix Metalloproteases (MMP) Gene Expression Profile and Their Diagnostic/Prognostic Potential. BMC Cancer, 19, 581.
https://doi.org/10.1186/s12885-019-5768-0
|
[10]
|
Hu, Z.L., Wen, J.F., Shen, M., et al. (2006) Expressions of TGIF, MMP9 and VEGF Proteins and Their Clinicopathological Relationship in Gastric Cancer. Journal of Central South University. Medical Sciences, 31, 70-74.
|
[11]
|
Zhang, W.J., Song, B. and Yang, T. (2019) MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma. Cancer Management and Research, 11, 10675-10681.
https://doi.org/10.2147/CMAR.S233776
|
[12]
|
Liu, X., Su, C., Xu, J., et al. (2019) Immunohistochemical Analysis of Matrix Metalloproteinase-9 Predicts Papillary Thyroid Carcinoma Prognosis. Oncology Letters, 17, 2308-2316. https://doi.org/10.3892/ol.2018.9850
|
[13]
|
张建军, 刘志明. MMP-9及TIMP-1在甲状腺癌组织及外周血中的表达及临床意义[J]. 中国普外基础与临床杂志, 2007, 14(4): 437-441.
|
[14]
|
张金江, 尚培中, 刘景章, 等. 基质金属蛋白酶-9在甲状腺良恶性病变组织中表达及临床意义[J]. 华北国防医药, 2008, 20(2): 8-10+85.
|
[15]
|
许力, 赵中辛, 李仁志, 等. NF-kB和MMP-9在甲状腺乳头状癌中的表达及意义[J]. 安徽卫生职业技术学院学报, 2009, 8(3): 83-85.
|
[16]
|
李艳萍, 庾英兰, 关宝生, 等. MMP-2、MMP-9、CD147在甲状腺乳头状癌中的表达[J]. 黑龙江医药科学, 2010, 33(2): 41-42.
|
[17]
|
周少飞, 毛伟征, 苗蕾, 等. 基质金属蛋白酶-9及其抑制剂与甲状腺乳头状癌的关系[J]. 疑难病杂志, 2012, 11(9): 676-678.
|
[18]
|
李良毅, 林玲, 邱建龙. 基质金属蛋白酶-9在甲状腺肿瘤组织中的表达[J]. 福建医药杂志, 2012, 34(4): 85-86.
|
[19]
|
王朝晖, 李玉中, 宋丽媛, 等. TSHR和MMP-9在甲状腺乳头状癌组织中的表达及其临床意义[J]. 大连医科大学学报, 2012, 34(5): 443-445+454.
|
[20]
|
Meng, X.Y., Zhang, Q., Li, Q., et al. (2014) Immunohistochemical Levels of Cyclo-Oxygenase-2, Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor in Papillary Thyroid Carcinoma and Their Clinicopathological Correlations. Journal of International Medical Research, 42, 619-627. https://doi.org/10.1177/0300060513505485
|
[21]
|
刘咏, 吴秀葵, 黄昕, 等. 基质金属蛋白酶-9和骨桥蛋白在甲状腺癌和腺瘤组织中的表达及其临床意义[J]. 中华实验外科杂志, 2015, 32(1): 151-153.
|
[22]
|
郜静, 王丽. 血清MMP-9、OPN表达水平与甲状腺癌患者颈部淋巴结转移及包膜浸润的关联性[J]. 中国卫生工程学, 2018, 17(5): 773-775.
|
[23]
|
Stang, A. (2010) Critical Evaluation of the Newcastle-Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta-Analyses. European Journal of Epidemiology, 25, 603-605.
https://doi.org/10.1007/s10654-010-9491-z
|
[24]
|
Wong, R., Farrell, S.G. and Grossmann, M. (2018) Thyroid Nodules: Diagnosis and Management. The Medical Journal of Australia, 209, 92-98. https://doi.org/10.5694/mja17.01204
|
[25]
|
Essig, G.F., Porter, K., Schneider, D., et al. (2013) Fine Needle Aspiration and Medullary Thyroid Carcinoma: The Risk of Inadequate Preoperative Evaluation and Initial Surgery When Relying upon FNAB Cytology Alone. Endocrine Practice, 19, 920-927. https://doi.org/10.4158/EP13143.OR
|
[26]
|
Shield, P.W., Crouch, S.J., Papadimos, D.J., et al. (2018) Identification of Metastatic Papillary Thyroid Carcinoma in FNA Specimens Using Thyroid Peroxidase Immunohistochemistry. Cytopathology, 29, 227-232.
https://doi.org/10.1111/cyt.12531
|
[27]
|
Bellevicine, C., Migliatico, I., Sgariglia, R., et al. (2020) Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg Alterations in Different Bethesda Diagnostic Categories: A Multicentric Prospective Study on the Validity of the 7-Gene Panel Test in 1172 Thyroid FNAs Deriving from Different Hospitals in South Italy. Cancer Cytopathology, 128, 107-118. https://doi.org/10.1002/cncy.22217
|
[28]
|
Malemud, C.J. (2006) Matrix Metalloproteinases (MMPs) in Health and Disease: An Overview. Frontiers in Bioscience, 11, 1696-1701. https://doi.org/10.2741/1915
|
[29]
|
Mondal, S., Adhikari, N., Banerjee, S., et al. (2020) Matrix Metalloproteinase-9 (MMP-9) and Its Inhibitors in Cancer: A Minireview. European Journal of Medicinal Chemistry, 194, Article ID: 112260.
https://doi.org/10.1016/j.ejmech.2020.112260
|
[30]
|
Wu, Z., He, D., Zhao, S., et al. (2019) IL-17A/IL-17RA Promotes Invasion and Activates MMP-2 and MMP-9 Expression via p38 MAPK Signaling Pathway in Non-Small Cell Lung Cancer. Molecular and Cellular Biochemistry, 455, 195-206. https://doi.org/10.1007/s11010-018-3483-9
|
[31]
|
Yang, C., Luo, L., Bai, X., et al. (2020) Highly-Expressed micoRNA-21 in Adipose Derived Stem Cell Exosomes Can Enhance the Migration and Proliferation of the HaCaT Cells by Increasing the MMP-9 Expression through the PI3K/AKT Pathway. Archives of Biochemistry and Biophysics, 681, Article ID: 108259.
https://doi.org/10.1016/j.abb.2020.108259
|
[32]
|
Zhu, W., Wu, X., Yang, B., et al. (2019) miR-188-5p Regulates Proliferation and Invasion via PI3K/Akt/MMP-2/9 Signaling in Keloids. Acta Biochimica et Biophysica Sinica (Shanghai), 51, 185-196.
https://doi.org/10.1093/abbs/gmy165
|
[33]
|
Wei, J., Fu, Y., Mao, X., et al. (2019) Decreased Filamin b Expression Regulates Trophoblastic Cells Invasion through ERK/MMP-9 Pathway in Pre-Eclampsia. Ginekologia Polska, 90, 39-45. https://doi.org/10.5603/GP.2019.0006
|
[34]
|
Yu, Y., Li, H., Xue, B., et al. (2014) SDF-1/CXCR7 Axis Enhances Ovarian Cancer Cell Invasion by MMP-9 Expression through p38 MAPK Pathway. DNA and Cell Biology, 33, 543-549. https://doi.org/10.1089/dna.2013.2289
|
[35]
|
Min, J., Feng, Q., Liao, W., et al. (2018) IFITM3 Promotes Hepatocellular Carcinoma Invasion and Metastasis by Regulating MMP9 through p38/MAPK Signaling. FEBS Open Bio, 8, 1299-1311.
https://doi.org/10.1002/2211-5463.12479
|
[36]
|
Liu, L., Ye, Y. and Zhu, X. (2019) MMP-9 Secreted by Tumor Associated Macrophages Promoted Gastric Cancer Metastasis through a PI3K/AKT/Snail Pathway. Biomedicine & Pharmacotherapy, 117, Article ID: 109096.
https://doi.org/10.1016/j.biopha.2019.109096
|
[37]
|
Fu, L., Xie, C.Y., Li, Q.C., et al. (2015) CRKL Promotes Lung Cancer Cell Invasion through ERK-MMP9 Pathway. Molecular Carcinogenesis, 54, E35-E44. https://doi.org/10.1002/mc.22148
|